ADENOVIRUS - ANVISA Registration 10338930334
Access comprehensive regulatory information for ADENOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930334 and manufactured by EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10338930334
25351111592202500
93741726000166
Company Information
Dates and Status
Aug 18, 2025
VIGENTE
09/18/2025 19:00:01
ADENOVÍRUS
Família Adenovirus Antigen Fluorescence Rapid Test Cassette (Swab)
ZHEJIANG ORIENT GENE BIOTECH CO., LTD.
82444370260
Sep 01, 2025
ADENOVÍRUS
RIDASCREEN® Adenovirus
R-BIOPHARM AG
82890930001
Jan 27, 2025
ADENOVÍRUS
VIASURE Adenovirus Real Time PCR Detection Kit
CERTEST BIOTEC, S.L.
82149920103
Jan 27, 2025
ADENOVÍRUS
Família Adenovirus Run Control
EXACT DIAGNOSTICS
80020690436
Dec 23, 2024
ADENOVÍRUS
Kit de Teste para Antígeno de Adenovírus (Ouro Coloidal)
ANHUI DEEPBLUE MEDICAL TECHNOLOGY CO., LTD.
82444370078
Nov 13, 2023

